StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
BofA/Merrill Lynch Reinstates Quest Diagnostics (DGX) at Buy
October 19, 2018 6:09 AM
BofA/Merrill Lynch analyst Derik de Bruin reinstates coverage on Quest Diagnostics ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
New Coverage
Next Articles
Quest Diagnostics (DGX) Reports In-Line Q3 EPS, Revenues Miss; Lowers FY18 EPS/Reveunes Outlook
October 23, 2018 6:48 AM
Quest Diagnostics (DGX) Reports Acquisition of Hurley Medical Center's Outreach Laboratory Services Operation in Central Michigan
October 22, 2018 9:32 AM
